Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on D Amino Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113292495B details a high-yield synthesis of (S)-amino benazepril intermediate using quinine-derived catalysis, offering significant cost and safety advantages for API manufacturing.
Patent CN105348144B details a high-purity synthetic route for Simeprevir intermediates, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN101368199A details immobilized enzyme hydrolysis for high-purity D-amino acids. This green process ensures stable supply chain and cost reduction in pharmaceutical intermediates manufacturing.
Advanced catalytic process for NEP inhibitor intermediates offering superior stereoselectivity. Discover cost-effective manufacturing solutions for complex amino acid derivatives.
Patent CN102822184B reveals a novel dehydration condensation method for L-AMPB intermediates, offering superior Z-selectivity and scalable manufacturing for global supply chains.
Novel patent CN112375015B offers high-purity synthesis route for pharmaceutical intermediates. Reduces steps and waste significantly while ensuring scalable production reliability for global supply chains.
Patent CN102241663B reveals a green aqueous synthesis for Strontium Ranelate. Achieve 90-95% yield with <0.3% impurities. Ideal for cost reduction in API manufacturing.
Patent CN107129444A reveals a novel purification strategy for Eluxadoline intermediates, ensuring >99% purity and robust commercial scalability for global supply chains.
Patent CN102516351A details novel ursolic acid derivatives with enhanced anti-cancer activity and reduced toxicity, offering cost reduction in API manufacturing.
Patent CN102936214B details a green synthesis of H acid using mother liquor recycling and hydrogenation, reducing waste by over 80% for reliable dye intermediate supply.
Advanced patent CN104860975B enables cost-effective bortezomib intermediate production. Enhanced yield and purity for reliable pharmaceutical supply chains.
Patent CN102584674B reveals metal-free synthesis technology. Offers significant cost reduction and supply reliability for pharmaceutical intermediates manufacturing partners seeking high purity.
Novel Ru-catalyzed asymmetric hydrogenation route for Niraparib intermediate. High yield, scalable process for pharmaceutical supply chains.
Novel rhodium-catalyzed one-step synthesis offers high selectivity and supply chain stability for pharmaceutical intermediates manufacturing ensuring reliable sourcing for global drug development pipelines.
Patent CN102391243B details a high-yield route for atorvastatin side chain intermediates, offering significant cost reduction and supply chain reliability for API manufacturers.
Patent CN116102488B details a high-yield synthesis route for 2 3 diaminopropionic acid derivatives using L-serine offering significant cost and supply chain advantages for pharmaceutical manufacturers
Novel synthesis method for 2,3-diaminopropionic acid derivatives using L-serine. Offers high yield, mild conditions, and scalable production for pharmaceutical applications.
Patent CN102153512B reveals a mixed-acid hydrolysis method for Rebamipide intermediates, offering superior yield and purity for global supply chains.
Patent CN111763181A reveals a mild phosphine-catalyzed Mannich reaction for benzosultam derivatives, offering cost reduction and scalable pharma intermediate manufacturing.
Novel route for Iopamidol production via acylated intermediate. High purity, reduced impurities, and cost-effective manufacturing for global supply chains.